Liu Wen-dan, Tan Li, Xiong Xi-feng, Liang Ye-ping, Tan Huo
Center of Oncology and Hematology, the First Affiliated Hospital of Guangzhou Medical College, Guangzhou 510230, China.
Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):448-52.
To explore the effects of lentivirus-mediated RNA interference silencing HMGA2 on proliferation and expressions of cyclin B2 and cyclin A2 in HL-60 cell line.
The protein and mRNA expressions of HMGA2 in HL-60 cells transduced by recombinant lentivirus producing HMGA2 gene short hairpin (shRNA) were examined by Western-blot and reverse transcription-polymerase chain reaction (RT-PCR) analysis; The effects of the lentivirus on cell proliferation inhibiting rate, the ability of cell proliferation and cell cycle were analyzed by soft agar colony formation assay and FCM, respectively; The protein and mRNA expressions of cyclin B2 and cyclin A2 were also examined by Western-blot and RT-PCR.
Recombinant lentivirus producing HMGA2 shRNA was successfully constructed, which was identified by PCR and sequencing; Stable HMGA2-deficient HL-60 cell line was established by puromycin, its mRNA and protein expression inhibition rates were (80.66 ± 7.98)% and (76.35 ± 12.72)%, respectively. Silencing of endogenous HMGA2 resulted in efficient inhibition of the cellular proliferative activity, low and flat of the cell growth curve and the lack of typical character of exponential growth. FCM revealed significant more cell cycle G(2)/M arrest [(30.00 ± 5.78)%] in HL-60 cell line transfected specific shRNA than control group [(13.90 ± 4.07)%] (P < 0.05). The cyclin B2 mRNA and protein expression inhibition rates in stable HMGA2-deficient HL-60 cell line were (67.55 ± 7.69)% and (51.77 ± 4.81)%, respectively, while the expression of cyclin A2 had no significant change compared with control group.
RNAi silencing of HMGA2 down-regulated cyclinB2, significantly inhibited the proliferation of HL-60 cells and induced the accumulation of HL-60 cells in the G(2)/M phase. Thus, HMGA2 may be an important target for anti-leukemia therapy.
探讨慢病毒介导的RNA干扰沉默HMGA2对HL-60细胞系增殖及细胞周期蛋白B2和细胞周期蛋白A2表达的影响。
采用蛋白质免疫印迹法(Western-blot)和逆转录-聚合酶链反应(RT-PCR)分析经重组慢病毒转导产生HMGA2基因短发夹(shRNA)的HL-60细胞中HMGA2的蛋白和mRNA表达;分别采用软琼脂集落形成试验和流式细胞术(FCM)分析慢病毒对细胞增殖抑制率、细胞增殖能力及细胞周期的影响;同时采用Western-blot和RT-PCR检测细胞周期蛋白B2和细胞周期蛋白A2的蛋白和mRNA表达。
成功构建了产生HMGA2 shRNA的重组慢病毒,经PCR及测序鉴定;用嘌呤霉素筛选建立了稳定的HMGA2缺失HL-60细胞系,其mRNA和蛋白表达抑制率分别为(80.66±7.98)%和(76.35±12.72)%。内源性HMGA2沉默导致细胞增殖活性有效抑制,细胞生长曲线低平,缺乏典型的指数生长特征。FCM显示,转染特异性shRNA的HL-60细胞系中细胞周期G(2)/M期阻滞明显增多[(30.00±5.78)%],高于对照组[(13.90±4.07)%](P<0.05)。稳定的HMGA2缺失HL-60细胞系中细胞周期蛋白B2的mRNA和蛋白表达抑制率分别为(67.55±7.69)%和(51.77±4.81)%,而细胞周期蛋白A2的表达与对照组相比无明显变化。
RNA干扰沉默HMGA2可下调细胞周期蛋白B2,显著抑制HL-60细胞增殖,并诱导HL-60细胞在G(2)/M期蓄积。因此,HMGA2可能是抗白血病治疗的重要靶点。